Study identifier:D5180R00025
ClinicalTrials.gov identifier:NCT05922891
EudraCT identifier:N/A
CTIS identifier:N/A
Effectiveness of Tezepelumab on Asthma control and Cough: A prospective, multi-center, observational study
asthma
N/A
No
-
All
92
Observational
18 Years - 130 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|